Sentinel Pension Advisors Inc Spero Therapeutics, Inc. Transaction History

Sentinel Pension Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$0.68 - $2.2 $20,400 - $66,000	-30,000 Reduced 71.43%	12,000 $24,000
Q1 2022 May 06, 2022	BUY	$7.87 - $15.15 $92,866 - $178,770	11,800 Added 39.07%	42,000 $365,000
Q4 2021 Feb 08, 2022	BUY	$13.09 - $18.77 $130,900 - $187,700	10,000 Added 49.5%	30,200 $484,000
Q3 2021 Oct 20, 2021	BUY	$13.03 - $19.51 $263,206 - $394,102	20,200 New	20,200 $372,000
Q2 2021 Jul 12, 2021	SELL	$12.22 - $15.79 $322,730 - $417,013	-26,410 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$13.23 - $21.48 $36,977 - $60,036	2,795 Added 11.84%	26,410 $425,000
Q4 2020 Jan 29, 2021	BUY	$11.65 - $22.07 $275,114 - $521,183	23,615 New	23,615 $458,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Sentinel Pension Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Sentinel Pension Advisors Inc with notifications on news.